DE69002865T2 - Orale Zubereitung. - Google Patents

Orale Zubereitung.

Info

Publication number
DE69002865T2
DE69002865T2 DE90107387T DE69002865T DE69002865T2 DE 69002865 T2 DE69002865 T2 DE 69002865T2 DE 90107387 T DE90107387 T DE 90107387T DE 69002865 T DE69002865 T DE 69002865T DE 69002865 T2 DE69002865 T2 DE 69002865T2
Authority
DE
Germany
Prior art keywords
oral preparation
oral
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90107387T
Other languages
English (en)
Other versions
DE69002865D1 (de
Inventor
Takehisa Hata
Hiromitsu Yoshida
Takao Yamamoto
Takashi Saito
Hisami Yamaguchi
Keiji Imai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE69002865D1 publication Critical patent/DE69002865D1/de
Application granted granted Critical
Publication of DE69002865T2 publication Critical patent/DE69002865T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE90107387T 1989-04-20 1990-04-19 Orale Zubereitung. Expired - Fee Related DE69002865T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10140389 1989-04-20

Publications (2)

Publication Number Publication Date
DE69002865D1 DE69002865D1 (de) 1993-09-30
DE69002865T2 true DE69002865T2 (de) 1994-01-05

Family

ID=14299762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90107387T Expired - Fee Related DE69002865T2 (de) 1989-04-20 1990-04-19 Orale Zubereitung.

Country Status (5)

Country Link
EP (1) EP0398033B1 (de)
JP (1) JPH0347124A (de)
KR (1) KR900015732A (de)
CA (1) CA2014926A1 (de)
DE (1) DE69002865T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007491A1 (en) * 1992-10-05 1994-04-14 Fujisawa Pharmaceutical Co., Ltd. Analgesic, anticonjunctivitic or chronic rheumatism remedy containing quinolizinone compound or salt thereof, and preparation for topical application thereof
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
EA004872B1 (ru) * 1999-08-03 2004-08-26 ЛИЛЛИ АЙКОС эЛ-эЛ-Си β-КАРБОЛИНОВЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
KR100908418B1 (ko) * 2001-06-20 2009-07-21 액티버스 파마 컴퍼니 리미티드 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법
EP1819323B2 (de) * 2004-12-03 2023-03-22 Merck Sharp & Dohme Corp. Pharmazeutische zusammensetzung mit anti-keimbildner

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
ZA885263B (en) * 1987-07-28 1989-03-29 Fujisawa Pharmaceutical Co Crystalline monohydrate of sodium n-(1h-tetrazol-5-yl)-1-phenoxy-4h-quinolizin-4-one-3-carboxamide

Also Published As

Publication number Publication date
CA2014926A1 (en) 1990-10-20
EP0398033B1 (de) 1993-08-25
KR900015732A (ko) 1990-11-10
JPH0347124A (ja) 1991-02-28
EP0398033A1 (de) 1990-11-22
DE69002865D1 (de) 1993-09-30

Similar Documents

Publication Publication Date Title
IT1237483B (it) Composizione orale antibatterica antiplacca.
DE68901492D1 (de) Orale zusammensetzungen.
ES2015061B3 (es) Ingrediente antiespuma.
DE69014358D1 (de) Kosmetisches Präparat.
DE68903192T2 (de) Orale praeparate.
DE68917544T2 (de) Durchsichtiges Präparat.
DE69007080T2 (de) Orale Hygienezusammensetzung.
DK314089A (da) Orale praeparater
DE68902629D1 (de) Orale zusammensetzung.
DE68904099D1 (de) Badepraeparat.
DE69008682D1 (de) Guanidinobenzolderivate.
NO873080D0 (no) Mikrobicid tilberedning.
DE69012702D1 (de) Dentalzusammensetzung.
DE3852599T2 (de) Orale Zusammensetzungen.
DE69022965T2 (de) Aminopiperazinderivate.
ATE124407T1 (de) Chromanderivate.
ATE116985T1 (de) Chromanderivate.
DE69017657D1 (de) Pyridinderivate.
DK16489A (da) Immunstimulerende praeparat.
DE69002865D1 (de) Orale Zubereitung.
DE69005904T2 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE68910125T2 (de) Oral-Präparate.
FI900798A0 (fi) Foerfarande foer gjutning av fiberfoerstaerkta plaster.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee